Chromadex Corp
NASDAQ:CDXC

Watchlist Manager
Chromadex Corp Logo
Chromadex Corp
NASDAQ:CDXC
Watchlist
Price: 5.49 USD 1.48%
Market Cap: 419.3m USD
Have any thoughts about
Chromadex Corp?
Write Note

Chromadex Corp
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Chromadex Corp
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Chromadex Corp
NASDAQ:CDXC
Total Current Assets
$52.1m
CAGR 3-Years
0%
CAGR 5-Years
7%
CAGR 10-Years
24%
Thermo Fisher Scientific Inc
NYSE:TMO
Total Current Assets
$23.8B
CAGR 3-Years
-1%
CAGR 5-Years
18%
CAGR 10-Years
15%
Danaher Corp
NYSE:DHR
Total Current Assets
$10.1B
CAGR 3-Years
-2%
CAGR 5-Years
-13%
CAGR 10-Years
0%
Mettler-Toledo International Inc
NYSE:MTD
Total Current Assets
$1.2B
CAGR 3-Years
-1%
CAGR 5-Years
4%
CAGR 10-Years
3%
Agilent Technologies Inc
NYSE:A
Total Current Assets
$4B
CAGR 3-Years
1%
CAGR 5-Years
4%
CAGR 10-Years
-3%
IQVIA Holdings Inc
NYSE:IQV
Total Current Assets
$5.6B
CAGR 3-Years
7%
CAGR 5-Years
7%
CAGR 10-Years
11%
No Stocks Found

Chromadex Corp
Glance View

Market Cap
417.4m USD
Industry
Life Sciences Tools & Services

Chromadex Corp. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. The company is headquartered in Los Angeles, California and currently employs 115 full-time employees. The company went IPO on 2007-06-25. NAD+ is a coenzyme and a regulator of cellular metabolism. The company operates through three segments: Consumer products, Ingredients, and Analytical reference standards and services segment. The Consumer products segment provides finished dietary supplement products that contain the ingredients directly to consumers as well as to distributors. The Ingredients segment develops and commercializes ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The Analytical reference standards and services segment supplies phytochemical reference standards and other research and development services. Its ingredients include Tru Niagen and Immulina. The Tru Niagen is a form nicotinamide riboside (NR). NR is a member of the vitamin B3 family. Immulina is a spirulina extract.

CDXC Intrinsic Value
2.28 USD
Overvaluation 58%
Intrinsic Value
Price

See Also

What is Chromadex Corp's Total Current Assets?
Total Current Assets
52.1m USD

Based on the financial report for Sep 30, 2024, Chromadex Corp's Total Current Assets amounts to 52.1m USD.

What is Chromadex Corp's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
24%

Over the last year, the Total Current Assets growth was 11%.

Back to Top